Zhifeng Huang

Wenzhou, 325035, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

FGF4-FGFR1 signaling promotes podocyte survival and glomerular function to ameliorate diabetic kidney disease in male mice.

FGF4-FGFR1 signaling promotes podocyte survival and glomerular function to ameliorate diabetic kidney disease in male mice.

Journal: Nature communications

Published: January 25, 2025

A two-strata energy flux system driven by a stress hormone prioritizes cardiac energetics.

A two-strata energy flux system driven by a stress hormone prioritizes cardiac energetics.

Journal: Signal transduction and targeted therapy

Published: January 15, 2025

An adaptive AI-based virtual reality sports system for adolescents with excess body weight: a randomized controlled trial.

An adaptive AI-based virtual reality sports system for adolescents with excess body weight: a randomized controlled trial.

Journal: Nature medicine

Published: November 19, 2024

Colonic epithelial-derived FGF1 drives intestinal stem cell commitment toward goblet cells to suppress inflammatory bowel disease.

Colonic epithelial-derived FGF1 drives intestinal stem cell commitment toward goblet cells to suppress inflammatory bowel disease.

Journal: Nature communications

Published: October 11, 2024

Repression of the ERRγ-CYP2E1 pathway by FGF4 mitigates alcohol-associated liver injury.

Repression of the ERRγ-CYP2E1 pathway by FGF4 mitigates alcohol-associated liver injury.

Journal: Hepatology (Baltimore, Md.)

Published: September 27, 2024

FGF2 Mediated USP42-PPARγ Axis Activation Ameliorates Liver Oxidative Damage and Promotes Regeneration.

FGF2 Mediated USP42-PPARγ Axis Activation Ameliorates Liver Oxidative Damage and Promotes Regeneration.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 28, 2024

Erratum: Author correction to 'FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis' [Acta Pharm Sin B 14 (2024) 1605-1623].

Erratum: Author correction to 'FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis' [Acta Pharm Sin B 14 (2024) 1605-1623].

Journal: Acta pharmaceutica Sinica. B

Published: June 03, 2024

Hepatic FXR-FGF4 is required for bile acid homeostasis via an FGFR4-LRH-1 signal node under cholestatic stress.

Hepatic FXR-FGF4 is required for bile acid homeostasis via an FGFR4-LRH-1 signal node under cholestatic stress.

Journal: Cell metabolism

Published: March 11, 2024

FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis.

FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis.

Journal: Acta pharmaceutica Sinica. B

Published: October 26, 2023

Fibroblast growth factor 21 ameliorates cholestatic liver injury via a hepatic FGFR4-JNK pathway.

Fibroblast growth factor 21 ameliorates cholestatic liver injury via a hepatic FGFR4-JNK pathway.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: July 05, 2023

Correction: FGF1ΔHBS ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation.

Correction: FGF1ΔHBS ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation.

Journal: Cell death & disease

Published: April 19, 2023

Hepatocyte leukotriene B4 receptor 1 promotes NAFLD development in obesity.

Hepatocyte leukotriene B4 receptor 1 promotes NAFLD development in obesity.

Journal: Hepatology (Baltimore, Md.)

Published: June 09, 2022

Showing 1-12 of 47

Last Updated: 09/26/2026